Reason
๋ณด์ ์ฑํฅ
๊ธฐํ
Is the Endangered Species Act Being Used to Commandeer State Governments?
A webinar discussion of whether we are seeing conservation commandeering.
๐บ๐ธ ๋ฏธ๊ตญ ยท "WEBINAR" ยท ์ด 7๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 11,352๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 1๊ฑด(0.0%)ยท์ค๋ฆฝ 11,350๊ฑด(100.0%)ยท๋ถ์ 1๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 19.0(์ค๋ ๊ท ํ)์ ๋๋ค.
A webinar discussion of whether we are seeing conservation commandeering.
As global competition intensifies, this new Breaking Defense webinar examines how research security policies and practices are evolving to protect federally funded innovation while maintaining open scientific collaboration.
The two companies will host a webinar later this month to share the goals and vision of the service, along with answering questions in real time.
This webinar presents a workflow offering end-to-end solutions for designing, training, validating and verifying, compressing, and deploying AI-based virtual sensor models to embedded processors within a single environment. Highlights Integrate AI models into Simulink for system-level simulation, verification, and simulation-based testing Apply formal verification techniques to assert neural network behavior Compress the AI model for memory footprint reduction and execution speedup Generate library-free C code from AI models and performing PIL tests Profile code performance and evaluate design and model selection tradeoffs Design and train AI-based virtual sensors using MATLAB Register now for this free webinar!
Patients who use mobile applications to manage medical conditions including depression and chronic pain might assume the apps have been evaluated by regulatory agencies to be safe and effective. But that isnโt necessarily the case. Most of the more than 55,000 medical apps that claim to diagnose or treat a conditionโor ones that provide clinical decision support, known as โtherapeuticโ appsโhave never been assessed by any trusted neutral bodies or regulatory agencies to evaluate them for technical soundness, ethical design, or clinical benefit. The apps often donโt comply with regional data security and privacy laws to protect peopleโs sensitive health information. Medical apps differ from traditional wellness apps, which provide users with insights into becoming healthier by, for example, tracking fitness activities, monitoring blood pressure, and analyzing sleep patterns. There is no reliable way to verify that therapeutic apps deliver the results they indicate. To help ensure such apps are credible, the IEEE Standards Association (IEEE SA) recently launched the IEEE Global Medical Mobile App Assessment and Registry. The publicly searchable directory is designed to list apps that have been vetted by experts across several criteria including technical soundness, ethical design, compliance with data security and privacy regulations, and clinical efficacy, which is evidence of a clinical benefit for the patient. โPatients, clinicians, payers, and health care systems often struggle to distinguish clinically meaningful therapeutic apps from those that are simply well-marketed,โ says IEEE Senior Member Yuri Quintana, chair of the assessment and registry program. He is chief of the clinical informatics division at Beth Israel Deaconess Medical Center, in Boston. โOur goal is to establish a standardized review method using criteria developed by experts.โ Why regulation is lacking Because the apps are intended for medical use without being part of a medical implement, they fall under the designation of software as a medical device (SaMD), according to the International Medical Device Regulators Forum. SaMD is supposed to be regulated by public health agencies such as the U.S. Food and Drug Administration, but the apps have developed and grown in popularity so quickly that regulators havenโt been able to keep up, Quintana says. Some companies have received approval, but most have not, he says. Many users are unaware of the regulatory gap, he says. โSeeing an app from a well-known company often creates the impression that it has been meaningfully vetted for safety and efficacy, even when that is not the case,โ he says. Some companies are using deceptive advertising to sell their product, he adds. Marketing materials might claim that all of a companyโs health apps are certified, even though only one app has been approved by a regulatory body to treat a particular condition. Or the verbiage might imply the company has clinical evidence proving its application works, even though the app has never been tested independently. Another concern is that updated apps arenโt being vetted, says Maria Palombini, IEEE SAโs director of health care and life sciences global practice lead. โThe original app might have received approval from a regulatory agency, but not the updated version,โ Palombini says. โThere could have been significant changes from the original.โ โNot every medical-related app triggers the same regulatory classification or review across jurisdictions,โ Quintana adds. โThat leaves a large gray zone of clinically relevant but lower-risk apps that havenโt undergone an independent assessment. The IEEE registry was created to help fill these gaps. โIEEE is the best organization to address this problem because this is fundamentally a standards, trust, interoperability, and conformity assessment challenge,โ he says. IEEE โis the worldโs largest technical professional organization, with deep expertise in developing globally recognized standards including in health care, cybersecurity, AI ethics, and interoperability.โ โThrough the IEEE Conformity Assessment Program, we already run rigorous assessment and registry programs,โ Palombini says. โOur neutral, consensus-driven, multidisciplinary approachโbringing together clinicians, regulators, developers, and ethicists without commercial biasโmakes IEEE uniquely positioned to create trustworthy global guardrails that can scale across jurisdictions and support regulatory harmonization.โ How the registry works The assessment framework was developed by a multidisciplinary group of 35 volunteer experts from 10 countries, Quintana says. The panel includes academics, AI experts, app developers, clinicians, ethicists, mental health experts, patient advocates, regulators, researchers, technologists, and those who assess safety in health care. The registry is for any app used for clinical care or therapeutics that claims to demonstrate a medical benefit. That includes apps designed for cardiology, diabetes, mental health, neurology, oncology, rehabilitation, and respiratory diseases, Quintana says. Initially, he says, the focus will be on apps that aim to treat mental health conditions, given the large number of offerings in that area and the registry committeeโs expertise. The submission of apps is voluntary. There is no government mandate that requires a company to use the IEEE registry. The products will be evaluated against about 150 consensus-based criteria across three major areas: Clinical efficacy including therapeutic effectiveness, any sustained benefits, risk management, comparison to standard care, user engagement, and real clinical value. Technical soundness including accessibility, privacy and security, error handling, interoperability, AI governance, usability, and operational quality. Ethical design including bias prevention, patient consent, data governance, conflict-of-interest transparency, responsible use of AI and large language models, and prioritization of public health benefits. IEEE charges a nonrefundable submission fee that covers the cost of the assessment plus the registryโs annual subscription for the first year. Developers first must demonstrate they are a legally established entity before they can complete the app publisher registration form and then submit documentation and attestations about the product. The IEEE review of an app is estimated to take six to eight weeks, Palombini says. The assessment results will be privately shared with the app publisher, she says, and to be listed in the registry, an app must achieve more than 85 percent compliance in each category. Upgraded apps must be submitted and reassessed, Palombini says. Similar to how users are notified when an app on their smart devices has , the registry will be notified when listed apps have a new update available, she says. Applicants who do not pass the assessment are to receive feedback explaining why. They will be given an opportunity to make changes or provide additional documentation, Palombini says. โItโs a pretty methodological process, with checks and balances,โ Quintana says. โWeโre being very transparent about the process.โ Approved apps added to the registry receive an IEEE certification badge and submission identifier, which the company can display on its website, app store listings, and marketing materials. โThe badge serves as visible proof that the app has met the independent, consensus-based assessment for clinical value, technical robustness, and ethical design,โ Quintana says. The registry will be publicly available at no cost, he says. Patients and families seeking safe, trustworthy appsโand payers and insurers evaluating reimbursement potentialโwill find the registry helpful, he says. The application website is open. The public registry page does not yet list a specific count of approved apps because assessments are ongoing. Approved apps and their unique identifiers are to be published when the initial reviews are completed. To learn more, you can watch a webinar recorded in March. The assessment framework that underpins the registry is supporting the formal recognition of IEEE P3962 Standard for Criteria Assessment Framework f
Discover how the ZEISS Crossbeam 750 FIBSEM sets a new benchmark for precise TEM lamella prep, tomography, and advanced nanofabrication. This delivers better resolution, better SNR, larger usable FOV, and shorter acquisition times. Learn how uninterrupted FIB milling will reduce damage and rework, accelerate time to TEM, and increase first pass successโso your FA, yield, and materials teams make faster, confident data driven decisions. Join us to discover how the new ZEISS Crossbeam 750 with its see while you mill capability delivers precision and clarityโevery timeโfor demanding FIB-SEM workflows. Designed for extremely challenging TEM lamella preparation, tomography, advanced nanofabrication, and APTโready liftโout, Crossbeam 750 combines a new Gemini 4 SEM objective lens, a double deflector, and a nextโgeneration scan generator to elevate both image quality and process confidence. Youโll learn how better resolution and better SNR translate into more image detail and shorter acquisition times, while the lowโkV FIB performance enables more precise lamella prep. Weโll demonstrate High Dynamic Range (HDR) Mill + SEMโan interwoven SEM/FIB scanning mode that suppresses FIBโgenerated background. This enables immediate, clean visual feedback, even during nudging the FIB pattern live while milling . The result: confident endpointing with uninterrupted FIB milling and pristine, metrologyโgrade surfaces with the lowest possible sample damage. This session is ideal for semiconductor failure analysists, yield teams and materials scientists seeking faster timeโtoโTEM, higher firstโpass success, and consistent outcomes at low kV. See how Crossbeam 750 empowers you to make earlier stopโmilling decisions, cut rework, and reliably plan turnaround timeโso you can move from sample to insight with confidence. Register now for this free webinar!
Laboratory or in-field measurements are often considered the gold standard for certain aspects of power system design; however, measurement approaches always have limitations. Simulation can help overcome some of these limitations, including speeding up the design process, reducing design costs, and assessing situations that are often not feasible to measure directly. In this presentation, we will discuss two examples from the power system industry. The first case we will discuss involves corona performance testing of high-voltage transmission line hardware. Corona-free insulator hardware performance is critical for operation of transmission lines, particularly at 500 kV, 765 kV, or higher voltages. Laboratory mockups are commonly used to prove corona performance, but physical space constraints usually restrict testing to a partial single-phase setup. This requires establishing equivalence between the laboratory setup and real-world three-phase conditions. In practice, this can be difficult to do, but modern simulation capabilities can help. The second case involves submarine HVDC cables, which are commonly used for offshore wind interconnects. HVDC cables are often considered to be environmentally inert from an external electric field perspective (i.e., electric fields are contained in the cable, and the cableโs static magnetic fields induce no voltages externally). However, simulation demonstrates that ocean currents moving through the static magnetic field satisfy the relative motion requirement of Faradayโs law. Thus, externally induced electric fields can exist around the cable and are within a range detectable by various aquatic species. Key Takeaway: Learn how to use modern simulation to translate single-phase laboratory corona mockups into accurate three-phase real-world performance for 500 kV and 765 kV systems. Explore the physics behind how ocean currents interacting with HVDC submarine cables create induced electric fieldsโa phenomenon often overlooked but detectable by aquatic species. Gain actionable insights into how to leverage simulation to reduce design costs and bypass the physical space constraints that often stall traditional testing. See a practical application of electromagnetic theory as we demonstrate how relative motion in static magnetic fields necessitates simulation where direct measurement is unfeasible. Register now for this free webinar!